Prevalence of concomitant medications in older HIV+ patients and comparison with general population

HIV Clinical Trials

Volumn 16, Issue 3, 2015, Pages 117-124

  Gimeno Gracia, Mercedes ^a   Crusells Canales, Maria Jose ^a   Armesto Gomez, Francisco Javier ^b   Rabanaque Hernandez, Maria Jose ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b Aragonese Health Service   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Aging; Antiretroviral therapy; Dosing; Drug utilization; HIV AIDS

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIANEMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; ANTITUSSIVE AGENT; ANTIVIRUS AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; DIURETIC AGENT; GASTROINTESTINAL AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RESPIRATORY TRACT AGENT; URINARY TRACT AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; POPULATION; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; VIRUS LOAD; AGE; COMORBIDITY; POLYPHARMACY;

AGE FACTORS; ANALGESICS; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIPSYCHOTIC AGENTS; COMORBIDITY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; POLYPHARMACY;

EID: 84943399563     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1179/1528433614Z.0000000012     Document Type: Article

References (24)

1. Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, et al. Morbidity and aging in HIV-infected persons: the swiss HIV cohort study. Clin Infect Dis. 2011;53: 1130-1139.
2. Blanco JR, Jarŕin I, Vallejo M, Berenguer J, Solera C, Rubio R, et al. Definition of advance age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses. 2012; 28:1000-1006.
3. Work Group for the HIV and Aging Consensus Project. Summary report from the human immunodeficiency virus and aging consensus project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60:974-979.
4. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126.
5. Justice AC. HIV and aging: time for new paradigm. Curr HIV/AIDS Rep. 2010;7:69-76.
6. Gleason LJ, Luque AE, Shah K. Polypharmacy in the HIV-infected older adult population. Clin Interv Aging. 2013;8: 749-763.
7. Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging. 2013;30:613-628.
8. Marzolini C, Elzi L, Gibbons S, Weber R, Fux C, Furrer H, et al. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther. 2010;15:413-423.
9. Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A, et al. Ageing with HIV: medication use and risk for potencial drug-drug interactions. J Antimicrob Chemother. 2011;66: 2107-2111.
10. Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, et al. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med. 2013;10:1302-1310.
11. Tseng A, Szadkowski L, Walmsley S, Salit I, Raboud J. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Ann Pharmacother. 2013;47:1429-1439.
12. WHOCC. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs. Oslo www.whocc.no/atc-ddd-index/. Accessed June, 2012 2012.
13. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989-995.
14. Richardson K, Ananou A, Lafortune L, Brayne C, Matthews FE. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 2011;28:547-560.
15. Marcum ZA, Amuan ME, Hanlon JT, Aspinall SL, Handler SM, Ruby CM, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions among older veterans. J Am Geriatr Soc. 2012;60:34-41.
16. Malo-Fumanal S, Rabanaque-Fernandez MJ, Feja-Solana C, Lallana-Alvarez MJ, Armesto-Gomez J, Bjerrum L. [Differences in outpatient antibiotic use between a Spanish region and Nordic country]. Enferm Infecc Microbiol Clin. 2014;32: 412-417.
17. Aguilar-Palacio I, Carrera-Lasfuentes P, Poblador-Plou B, Prados-Torres A, Rabanaque-Hernandez MJ. [Morbidity and drug consumption. Comparison of results between the National Health Survey and electronic medical records]. GacSamt 2014; 28:41-47.
18. Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis. 2002;35:1238-1243.
19. Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, et al. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;15: 1593-1601.
20. Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, et al. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials. 2010;11:100-109.
21. Blanco JR, Caro AM, Perez-Cachafeiro S, Gutierrez F, Iribarren JA, Gonzalez-Garćia J, et al. HIV infection and aging. AIDS Rev. 2010;12:218-230.
22. Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS. 2004;1:S49-S59.
23. Schmiemann G, Bahr M, Gurjanov A, Hummers-Pradier E. Differences between patient medication records held by general practitioners and the drugs actually consumed by the patients. Int J Clin Pharmacol Ther. 2012;50:614-617.
24. Furler MD, Einarson TR, Walmsley S, Millson M, Bendayan R. Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS. 2004; 18:568-586.